FREE Case Review (866) 588-0600

Taxotere Hair Loss Lawsuit Filed in Texas

A Texas woman who claims she went bald after undergoing chemotherapy with Sanofi’s Taxotere has filed a products liability lawsuit against the company.

A Texas woman has filed a products liability lawsuit (PDF) against Sanofi-Aventis alleging that the chemotherapy drug Taxotere (generic: docetaxel) caused her to go permanently bald.

Free Confidential Lawsuit Evaluation: If you or a loved one suffered permanent hair loss, alopecia or baldness after undergoing chemo with Taxotere, you should contact our law firm immediately. You may be entitled to compensation by filing a suit against the manufacturer and our lawyers can help.

What’s the Problem?

Plaintiff Alina S. Gorniak alleges that she was diagnosed with infiltrating ductal carcinoma of the left breast in January 2013, which her doctors began treating with Taxotere the following month. She proceeded to undergo a cycle of 6 chemotherapy treatments with the drug, which ended in June 2013.

Gorniak contends that after she completed her 6th round of chemo, she developed permanently disfiguring alopecia, or hair loss. Plaintiff claims these side effects caused her “severe and debilitating emotional distress,” and “impairment of the quality and enjoyment of life.”

Additionally, the complaint alleges that Taxotere is no more effective than other widely-available chemotherapy drugs which do not carry the risk of permanent hair loss, and that Sanofi was aware of the Alopecia risk with Taxotere years before lawsuits started being fied.

The lawsuit notes a 2005 study which found that 9.2% of cancer patients treated with Taxotere suffered from hair loss that persisted for a decade or more, and that in 2006 a Denver oncologist alerted Sanofi to the fact that over 6% of his patients who used the drug suffered from long-term or permanent alopecia.

Two other smaller studies published in 2011 also examined the association between Taxotere and permanent hair loss. One of these, published in the Annals of Oncology, found that permanent alopecia is a newly reported complication of the drug. The other, published in the American Journal of Dermatopathology, determined that taxane-containing chemotherapy medications could contribute to permanent hair loss.

Gorniak alleges a number of counts against Sanofi including product liability, fraud and deceit, and breach of warranty. She also cites counts of violation of Texas consumer protection laws and outrageous conduct on the part of the company.

Plaintiff states that in addition to the physical and mental anguish resulting from permanent alopecia, she has been unable to maintain a job due to the psychological stress accompanying her condition. Gorniak is seeking compensation for medical expenses, loss of earning capacity, physical and mental pain. The complaint was filed in the U.S. District Court for the Western District of Texas.

Do I Have a Taxotere Lawsuit?

The Pharmaceutical Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Taxotere lawsuits. We are handling individual litigation nationwide and currently accepting new alopecia cases in all 50 states.

Free Confidential Case Evaluation: Again, if you went bald, suffered permanent hair loss or alopecia from Taxotere, you should contact our law firm immediately. You may be entitled to a settlement by filing a suit and we can help.

Free Confidential Case Evaluation

Verified 100% Secure SiteTo contact us for a free review of your potential case, please fill out the form below or call us toll free 24 hrs/day by dialing: (866) 588-0600.
Awards & recognition